Predictors of survival in WHO-defined hypereosinophilic syndrome and idiopathic hypereosinophilia and the role of next-generation sequencing

Leukemia

Volumn 30, Issue 9, 2016, Pages 1924-1926

  Pardanani, A ^a   Lasho, T ^a   Wassie, E ^a   Finke, C ^a   Zblewski, D ^a   Hanson, C A ^a   Ketterling, R P ^a   Gangat, N ^a   Tefferi, A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN;

EOSINOPHIL COUNT; FOLLOW UP; GENETIC VARIABILITY; HEMATOPOIESIS; HEPATOSPLENOMEGALY; HUMAN; HYPEREOSINOPHILIA; HYPEREOSINOPHILIC SYNDROME; IDIOPATHIC DISEASE; LETTER; LEUKOCYTE COUNT; LYMPHOCYTE COUNT; NEXT GENERATION SEQUENCING; OVERALL SURVIVAL; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SOMATIC MUTATION; THROMBOCYTE COUNT; WORLD HEALTH ORGANIZATION; ADULT; AGED; CLASSIFICATION; FEMALE; GENETICS; HIGH THROUGHPUT SEQUENCING; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PROCEDURES; RETROSPECTIVE STUDY; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; HYPEREOSINOPHILIC SYNDROME; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84966667293     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/leu.2016.73     Document Type: Letter

References (15)

1. Tefferi A, Gotlib J, Pardanani A. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc 2010; 85: 158-164
2. Bain BJ, Gilliland DG, Horny HP, Vardiman JW. Myeloid and lymphoid neoplasms with eosinophilia and abnormalities of PDGFRA, PDGFRB or FGFR1. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds) WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 4th edn. International Agency for Research and Cancer (IARC): Lyon, France, 2008, pp 68-73
3. Bain BJ, Gilliland DG, Vardiman JW, Horny HP. Chronic eosinophilic leuekaemia, not otherwise specified. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H et al. (eds) WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues. International agency for research on cancer (IARC): Lyon, France, 2008, pp 51-53
4. Cogan E, Schandene L, Crusiaux A, Cochaux P, Velu T, Goldman M. Brief report: clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome. N Engl J Med 1994; 330: 535-538
5. Valent P, Klion AD, Horny HP, Roufosse F, Gotlib J, Weller PF et al. Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes. J Allergy Clin Immunol 2012; 130: 607-612 e9
6. Lasho T, Finke C, Zblewski D, Hanson CA, Ketterling RP, Butterfield JH et al. Concurrent activating KIT mutations in systemic mastocytosis. Br J Haematol 2015; 173: 153-156
7. Pardanani A, Lasho T, Barraco D, Patnaik M, Elala Y, Tefferi A. Next generation sequencing of myeloid neoplasms with eosinophilia harboring the FIP1L1-PDGFRA mutation. Am J Hematol 2015; 91: E10-E11
8. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17: 405-424
9. Pardanani A, Reichard KK, Zblewski D, Abdelrahman RA, Wassie EA, Morice WG et al. CD123 immunostaining patterns in systemic mastocytosis: differential expression in disease subgroups and potential prognostic value. Leukemia 2015; 30: 914-918
10. Tefferi A, Pardanani A. Myeloproliferative neoplasms: a contemporary review. JAMA Oncol 2015; 1: 97-105
11. Ward PS, Patel J, Wise DR, Abdel-Wahab O, Bennett BD, Coller HA et al. The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell 2010; 17: 225-234
12. Buscarlet M, Provost S, Bourgoin V, Luigina M, Busque L. Age-associated acquired mutations in hematopoietic cells predominantly affect epigenetic regulators TET2 and DNMT3A and are associated with distinct biological and hematological profiles. Blood 2015; 126
13. Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman PV, Mar BG et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med 2014; 371: 2488-2498
14. Chusid MJ, Dale DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine (Baltimore) 1975; 54: 1-27
15. Tefferi A, Rumi E, Finazzi G, Gisslinger H, Vannucchi AM, Rodeghiero F et al. Survival and prognosis among 1545 patients with contemporary polycythemia vera: an international study. Leukemia 2013; 27: 1874-1881